| P2093 | author name string | W Li | |
| | J Yang | |
| | P Hu | |
| | Z Y Wang | |
| | Y M Yang | |
| | H H Fan | |
| | R F Xie | |
| | Y N Ren | |
| P2860 | cites work | Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease | Q46909923 |
| | Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? | Q47254315 |
| | Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions. | Q50551784 |
| | A novel in vivo ovine model of transfusion-related acute lung injury (TRALI). | Q50568567 |
| | Neutrophil priming, caused by cell membranes and microvesicles in packed red blood cell units, is abrogated by leukocyte depletion at collection. | Q50656153 |
| | Platelets amplify inflammation in arthritis via collagen-dependent microparticle production | Q24627618 |
| | Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles | Q24655248 |
| | Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk | Q33362119 |
| | The platelet as an immune cell-CD40 ligand and transfusion immunomodulation | Q33937074 |
| | The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. | Q34118409 |
| | Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury | Q35849153 |
| | The emerging role of platelets in adaptive immunity | Q36379961 |
| | Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury | Q36539650 |
| | The pro-inflammatory effects of platelet contamination in plasma and mitigation strategies for avoidance | Q36950012 |
| | CD40 ligand (CD154) involvement in platelet transfusion reactions | Q37429101 |
| | Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis | Q37778858 |
| | Microparticles and acute lung injury | Q38021265 |
| | Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium | Q40423150 |
| | Characterization and application of two novel monoclonal antibodies against CD40L: epitope and functional studies on cell membrane CD40L and studies on the origin of soluble serum CD40L. | Q40526843 |
| | Human native soluble CD40L is a biologically active trimer, processed inside microsomes | Q41216181 |
| | Mirasol Pathogen Reduction Technology treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components | Q42792341 |
| | Endothelial microparticles induce inflammation in acute lung injury | Q43063722 |
| | Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets | Q43265578 |
| | Flow-cytometric measurement of respiratory burst in rat polymorphonuclear granulocytes: Comparison of four cell preparation procedures, and concentration-response evaluation of soluble stimulants | Q46728270 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 234-241 | |
| P577 | publication date | 2013-10-21 | |
| P1433 | published in | Vox Sanguinis | Q15708866 |
| P1476 | title | The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst | |
| P478 | volume | 106 | |